Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/29/2005WO2005090391A1 Novel tat complexes, and vaccines comprising them
09/29/2005WO2005090390A1 Novel assay for the separation and quantification of hemagglutinin antigens
09/29/2005WO2005090389A2 Isosteric transformation
09/29/2005WO2005090387A2 Histone h2a peptide derivatives and analogs and methods of use thereof
09/29/2005WO2005090386A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/29/2005WO2005090385A2 Compositions having antimicrobial activity and uses thereof
09/29/2005WO2005090381A1 Set1 proteins and uses therefor
09/29/2005WO2005090378A1 Ligands of the molecule fit (agt-121) and their pharmaceutical use
09/29/2005WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents
09/29/2005WO2005089812A2 Novel antibiotic alternatives
09/29/2005WO2005089810A1 Method of inducing bone by transferring human osteogenetic factor gene with the use of electroporation method
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089799A1 Cytotoxicity method using effector function of anti-fam3d antibody
09/29/2005WO2005089795A2 Infectious bursal disease virus antigenic isolates and vaccines
09/29/2005WO2005089792A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
09/29/2005WO2005089790A2 Y2/y4 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089789A2 Y2 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089788A1 Medicine for cancer therapy
09/29/2005WO2005089786A2 Y4 selective receptor agonists for therapeutic interventions
09/29/2005WO2005089737A2 Materials and methods for inhibiting wip1
09/29/2005WO2005089539A1 Transgenic model for alzheimer’s disease
09/29/2005WO2005089527A2 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores
09/29/2005WO2005089445A2 Follicle stimulating hormone superagonists
09/29/2005WO2005089429A2 Sfec, a sperm flagellar energy carrier protein
09/29/2005WO2005089252A2 Methods and compositions for the treatment of obesity
09/29/2005WO2005089229A2 Vpac1 selective antagonists and their pharmacological methods of use
09/29/2005WO2005089182A2 Improved bacterial host cell for the direct expression of peptides
09/29/2005WO2005089164A2 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
09/29/2005WO2005089101A2 Non-pathogenic listeria vaccine vectors and methods of treatment therewith
09/29/2005WO2005089093A2 Improved expression systems with sec-system secretion
09/29/2005WO2005089038A2 Method for cloning, expression and purification of the amyloid polypeptide from human pancreatic islets
09/29/2005WO2005078076A3 Tpl2 and its expression
09/29/2005WO2005074967A3 Progastrin derived peptides
09/29/2005WO2005063807A3 Treatment of coronary or peripheral ischemia
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005062053A3 Method and device for detecting feline immunodeficiency virus
09/29/2005WO2005056807A3 Bovine adeno-associated viral (baav) vector and uses thereof
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005056051A3 Hepatitis b vaccines and compositions
09/29/2005WO2005052169A3 Plant disease resistance and sar regulator protein
09/29/2005WO2005051989A3 Novel agents for the prevention of leishmaniosis
09/29/2005WO2005051985A3 Methods for purifying pertussis toxin and peptides useful therefor
09/29/2005WO2005046732A3 Methods and compositions for the inhibition of hiv-1 replication
09/29/2005WO2005045020A3 Enzymatic synthesis, modification and decomposition of silicon(iv) compounds and other metal(iv) compounds
09/29/2005WO2005028516A3 Albumin-binding derivatives of therapeutic peptides
09/29/2005WO2005024011A3 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
09/29/2005WO2005016964A3 Canine specific growth hormone releasing hormone
09/29/2005WO2005014792A3 Preservation of biomaterials with transported preservation agents
09/29/2005WO2005014787A3 Genetic elements conferring flower petal-specific transgene expression
09/29/2005WO2005012360A3 Binding molecules against sars-coronavirus and uses thereof
09/29/2005WO2005011584A3 Decorin proteoglycan inhibitor of fibrinogen blood clotting
09/29/2005WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
09/29/2005WO2004108939A8 Bav packaging regions and e1 transcriptional control regions
09/29/2005WO2004103292A3 Process for manufacture of nematode-extracted anticoagulant protein (nap)
09/29/2005WO2004103149B1 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity
09/29/2005WO2004092338A3 Compositions, splice variants and methods relating to cancer specific genes and proteins
09/29/2005WO2004089302A3 Posh polypeptides, complexes and related methods
09/29/2005WO2004076632A3 Methods of screening for trpm5 modulators
09/29/2005WO2004073609A3 Posh associated kinases and related methods
09/29/2005WO2004037991A3 Prkcb1 as modifier of branching morphogenesis and methods of use
09/29/2005US20050216974 Plant reproduction polynucleotides and methods of use
09/29/2005US20050216971 DNA having a nucleotide sequence encoding insecticidal proteins; chimeric genes and host cells and plants containing them
09/29/2005US20050216969 Insect resistant cotton seed: transformation events of cotton plants with one or more polynucleotide sequences inserted into specific site(s) within the genome of a cotton cell
09/29/2005US20050216968 Nucleotide sequences coding fertilization-independent endosperm polypeptide for use in controlling endosperm development in flowering plants
09/29/2005US20050216963 Prion-free transgenic ungulates
09/29/2005US20050216962 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
09/29/2005US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response
09/29/2005US20050215776 Expression vector comprising nucleotide sequences coding g protein coupled receptors for use in diagnosis, prevention and treatment of physiological or behavioral disorders
09/29/2005US20050215775 70 human secreted proteins
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215765 Method, use and kit for separating albumin from contaminants in a liquid
09/29/2005US20050215764 Tubulin containing assemblies having variable electroconductivity and/or polarity regions
09/29/2005US20050215630 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
09/29/2005US20050215508 Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 Nef
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215499 Lipoproteins as nucleic acid vectors
09/29/2005US20050215486 Peptidomimetic compounds, useful as antiviral agents
09/29/2005US20050215482 Modulating cell adhesion, cancer cell adhesion, cancer cell invasion, cancer metastasis, bone turnover and remodeling, VEGF synthesis, TGF-beta synthesis
09/29/2005US20050215481 Antimicrobial peptide, its analogs and antimicrobial composition comprising them
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050215478 Amino acid sequences capable of facilitating penetration across a biological barrier
09/29/2005US20050215477 Treating agonist disorderssuch asd diabetes, obesity, heart dysfunctions, AIDS-related wasting, and kidney, neurological, whole body growth disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
09/29/2005US20050215476 Amidated parathyroid hormone fragments and uses thereof
09/29/2005US20050215472 PSMA formulations and uses thereof
09/29/2005US20050215469 Reducing food intake; obesity; dietetics
09/29/2005US20050215467 Multimeric Apo A-I agonist compounds
09/29/2005US20050215465 Methods of inducing IL-10 production
09/29/2005US20050214944 Using single-stranded nucleic acids and homologus recombination to correct defects in tumor suppressor genes; treating and preventing cell proliferative disorders; gene therapy
09/29/2005US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene
09/29/2005US20050214937 Surface proteins of leptospira
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214909 Genes from a gene cluster
09/29/2005US20050214906 Means and methods for regulating gene expression
09/29/2005US20050214905 Novel compounds
09/29/2005US20050214904 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
09/29/2005US20050214903 O-superfamily conotoxin peptides
09/29/2005US20050214902 Method for albumin purification
09/29/2005US20050214900 Enzyme/tag binding and detection system
09/29/2005US20050214893 Identifying modulators for prevention and treatment of cell proliferative disorders; antitumor agents
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 2916